Evidence map›Paper›PMID 25355696›Full record

ArticleScience translational medicine2014

Nanoparticles: take only pictures, leave only footprints.

Peter L Choyke

Abstract readComment
In one paragraph

Article in Science translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Peter L ChoykeMolecular Imaging Program, Building 10, National Cancer Institute, Bethesda, MD 20892, USA. pchoyke@nih.gov.

Funding

Lymphatic ImagingZIABC010654 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2020
$4.8M
Lymphatic ImagingZ01BC010654 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2005 to 2008
$1.1M
Intramural NIH HHS Z01 BC010654
6 · The paper itself

Abstract

A phase I study of a tumor-targeted nanoshell in five patients documents an important milestone in the development of nanoparticles for molecular imaging in humans (Phillips et al., this issue).

Indexed as

EndoscopyNanoparticlesOptics and PhotonicsPositron-Emission TomographyCD47 AntigenFemaleHumansMaleUrinary Bladder NeoplasmsCD47 Antigen

Identifiers

PMID25355696
PMCPMC6330108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.